PTN - Palatin reported promising results in trial for ulcerative colitis treatment
2025-03-28 09:19:02 ET
More on Palatin Technologies
- Palatin Technologies, Inc. (PTN) Q2 2025 Earnings Call Transcript
- Palatin's gets Orphan Drug status for its treatment for obesity from genetic disorder
- Palatin Technologies prices 4.69M shares in direct offering
- Seeking Alpha’s Quant Rating on Palatin Technologies
- Historical earnings data for Palatin Technologies